Ginsenoside Rd glucosyltransferase is a pivotal Glycan Tool Enzyme in the biosynthesis of ginsenosides, particularly in the conversion of ginsenoside Rd to (20S)-ginsenoside Rb1. This UDP-glucose-dependent Glycosyltransferase catalyzes the addition of a β-D-glucopyranosyl group to the C-20 position of ginsenoside Rd, forming Rb1 with high efficiency. By leveraging ginsenoside Rd glucosyltransferase, researchers can achieve scalable, cost-effective synthesis of (20S)-ginsenoside Rb1, a compound with documented anti-inflammatory, neuroprotective, and cardiovascular benefits, thereby advancing its therapeutic applications.

Fig.1. Chemical structures of ginsenosides Rg3 & Rd12. (OA Literature) Fig.1 Chemical structures of ginsenosides Rg3 and Rd12.¹

Service Profile

Are you currently facing the limitations of low-yield botanical extraction, inconsistent saponin purity, or the high costs associated with traditional ginsenoside Rd isolation? Our custom ginsenoside Rd glucosyltransferase production service helps you obtain high-activity enzymes and achieve high-yield fermentative synthesis of rare ginsenosides through advanced structural biology, rational enzyme design, and high-throughput microbial expression platforms. We provide a seamless transition from genetic sequence to industrial-scale biocatalysis, ensuring your rare saponin production is both scalable and sustainable.

Custom Ginsenoside Rd Glucosyltransferase Production Workflow

In Silico Enzyme Modeling
Leveraging advanced computational tools, we integrate structural data to design a tailored enzyme architecture. This involves homology modeling to refine the linker region and optimize the hydrophobic binding pocket, ensuring compatibility with your substrate's unique chemical properties. Molecular dynamics simulations further validate substrate-enzyme interactions, enhancing catalytic efficiency and specificity.

Gene Synthesis & Codon Optimization
The engineered gene sequence undergoes comprehensive optimization for robust expression in your target host organism. This includes eliminating rare codons, adjusting GC content, and incorporating host-preferred motifs to minimize translational bottlenecks. Additionally, we integrate regulatory elements to maximize transcript stability and protein yield.

High-Throughput Expression Screening
A diverse panel of microbial strains is evaluated through small-scale fermentation trials. Soluble protein expression levels are quantified via SDS-PAGE and Western blot, while activity assays identify the strain with the highest functional enzyme production. This data-driven approach ensures the selection of the optimal host for scalable manufacturing.

Kinetic Profiling & Purification
Enzyme kinetics are characterized using LC-MS and fluorometric assays to determine Km, Vmax, and turnover rates. A streamlined, tag-free purification protocol combining ion exchange and size-exclusion chromatography achieves >99% purity while preserving catalytic activity. Endotoxin removal and buffer exchange ensure compatibility with downstream applications.

Scale-Up & Lyophilization
Transitioning to fed-batch stirred-tank bioreactors, we optimize fermentation parameters to maximize biomass and enzyme titer. The harvested enzyme is stabilized via advanced lyophilization, incorporating cryoprotectants to maintain activity during storage. The final product meets stringent specifications for long-term stability and ease of reconstitution.

Fig.2. Custom ginsenoside Rd glucosyltransferase production process. (Creative Biolabs AI) Fig.2 Manufacturing flow of custom ginsenoside Rd glucosyltransferase.

Find Out About Our Tailored Solutions

Core Strengths

Structure-Guided Enzyme Engineering
Unlike conventional methodologies, we employ crystal-structure-informed rational design to precisely optimize regiospecificity and catalytic turnover. By integrating molecular dynamics simulations and quantum mechanical calculations, we refine active-site architecture to enhance substrate binding affinity and minimize off-target reactions, ensuring >95% positional selectivity in complex glycosylation or oxidation processes.

Ultra-Low Endotoxin & HCP Contamination
We guarantee < 5 EU/mg endotoxin levels and < 0.1% host cell protein residuals, achieved through multi-stage chromatography and ultrafiltration/diafiltration. Final products undergo 100% identity testing via LC-MS/MS, ensuring safety for applications.

Multi-Substrate Flexibility for Diverse Ginsenoside Derivatives
Our enzyme engineering platform enables substrate promiscuity optimization, allowing a single glucosyltransferase variant to process multiple ginsenoside substrates with comparable efficiency. This reduces the need for multiple enzyme stocks and simplifies multi-step biosynthesis pathways for rare ginsenoside production.

Cryogenic Storage & Long-Term Stability Guarantee
Enzymes are lyophilized with trehalose-based stabilizers and stored at -80 °C, ensuring > 2-year shelf life without activity loss. For field applications, we offer ambient-stable formulations with 6-month stability. Each batch includes real-time stability data for regulatory submissions.

Customer Reviews

High Conversion Efficiency
"In our recent studies on ginsenoside biotransformation, the custom-engineered glucosyltransferase provided by Creative Biolabs demonstrated a 300% increase in Rh2-to-Rg3 conversion efficiency compared to wild-type enzymes. Critically, its ultra-high specificity eliminated byproduct formation, a game-changer for our pipeline's cost and speed."- 3 months ago, Dr. J** M.

Regulatory Compliance Support
"For our mRNA vaccine ancillary reagent development, securing glucosyltransferase with full traceability was non-negotiable. Their end-to-end support includes batch-specific certification and real-time QC data access."- 5 months ago, Dr. James K** W.

Applications

Pharmaceutical Drug Development

Ginsenoside Rd and its derivatives are being rigorously studied for their neuroprotective and anti-inflammatory properties. Our high-activity enzymes provide the gram-to-kilogram quantities of pure Rd required for clinical trials, ensuring that researchers are not limited by raw material scarcity.

Nutraceutical & Functional Food Production

As consumer demand for ginseng products grows, our enzymes allow manufacturers to enrich their extracts with specific, high-bioavailability ginsenosides. The use of fermentative synthesis ensures a pesticide-free, sustainable supply chain that is independent of agricultural land use.

Cosmetic Formulation & Topical Delivery

Rare saponins are increasingly used in high-end anti-aging formulations. By utilizing our engineered enzymes, cosmetic brands can produce ultra-pure Rd and Rg3 that meet the standards required for dermatological applications.

See How We Can Customize Our Help

FAQs

Q: What is the typical lead time for a custom ginsenoside Rd glucosyltransferase production run?

A: Standard sequences usually take 6-8 weeks from gene synthesis to final purified enzyme delivery. Complex engineering projects involving site-directed mutagenesis may take slightly longer.

Q: Can you produce enzymes that are stable in organic solvents?

A: Yes. We can perform rational design to improve the surface hydrophobicity of the enzyme or provide immobilized versions that retain activity in non-aqueous environments.

Q: How do your enzymes compare to botanical extracts in terms of purity?

A: Our enzymatic process yields Rd with >98 purity, whereas botanical extracts often contain a complex mixture of saponins and plant proteins that are difficult to separate.

Q: Can you engineer the enzyme for specific glycosylation patterns beyond Rd?

A: Yes. Our structure-guided design platform allows customization of the enzyme's active site to accommodate alternative sugar donors or acceptor substrates. We validate variants via HPLC-MS/MS to confirm >95% regioselectivity for your target product.

Extended Services

Custom (20S)-Ginsenoside Rb1 Production Service

Leveraging proprietary biosynthesis and AI-optimized fermentation, we deliver pharmaceutical-grade (20S)-ginsenoside Rb1 with >99% enantiomeric purity and 50% lower production costs versus chemical synthesis.

Glycoproteomics Quantitative Analysis Services

Our high-throughput LC-MS/MS platform integrates site-specific glycosylation mapping and AI-driven biomarker discovery, enabling 10x faster quantification of glycoprotein signatures in complex biological samples for precision oncology and neurodegenerative disease research.

Reach Out to Us

Creative Biolabs is your premier partner for high-end enzyme engineering and protein production. From the structural analysis of complex glycosyltransferases to the industrial scale-up of therapeutic catalysts, we provide the technical expertise and manufacturing rigor required to advance your biopharmaceutical or biocatalytic project. For detailed project discussions, technical consultations, or to receive a formal quotation, please reach out to our global scientific support team.

Reference

Hu, Yumei, et al. "Biocatalytic synthesis of a novel bioactive ginsenoside using UDP-glycosyltransferase from Bacillus subtilis 168." Catalysts 10.3 (2020): 289. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/catal10030289

For Research Use Only.

Related Services

Online Inquiry